Based on the Nuwellis Inc stock forecast from 0 analysts, the average analyst target price for Nuwellis Inc is not available over the next 12 months. Nuwellis Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Nuwellis Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Nuwellis Inc’s stock price was USD 0.90. Nuwellis Inc’s stock price has changed by +18.87% over the past week, -22.41% over the past month and -92.96% over the last year.
No recent analyst target price found for Nuwellis Inc
No recent average analyst rating found for Nuwellis Inc
Company Overview Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. It offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. The company's Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. It sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. Read Less
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. It offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. The...Read More
Frequently Asked Questions About Nuwellis Inc (NUWE) Stock
Stock Target Advisor's fundamental analysis for Nuwellis Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on NUWE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on NUWE's stock to indicate what its average analyst target is.
NUWE stock's Price/Earning ratio is 0.02.
Our analysis grades NUWE stock's Price / Earning ratio at A-. This means that NUWE stock's Price/Earning ratio is above 8.999999999999996% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this NUWE may be undervalued for its sector.
The last closing price of NUWE's stock was USD 0.90.
The most recent market capitalization for NUWE is USD 4.08M.
Unfortunately we do not have enough analyst data on NUWE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Nuwellis Inc's stock.
As per our most recent records Nuwellis Inc has 38 Employees.
Nuwellis Inc's registered address is 12988 Valley View Road, Eden Prairie, MN, United States, 55344.
You can get more information about it from Nuwellis Inc's website at https://www.nuwellis.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About Nuwellis Inc (NUWE) Stock
Stock Target Advisor's fundamental analysis for Nuwellis Inc's stock is Slightly Bearish.
Unfortunately we do not have enough data on NUWE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on NUWE's stock to indicate what its average analyst target is.
NUWE stock's Price/Earning ratio is 0.02.
Our analysis grades NUWE stock's Price / Earning ratio at A-. This means that NUWE stock's Price/Earning ratio is above 8.999999999999996% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this NUWE may be undervalued for its sector.
The last closing price of NUWE's stock was USD 0.90.
The most recent market capitalization for NUWE is USD 4.08M.
Unfortunately we do not have enough analyst data on NUWE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Nuwellis Inc's stock.
As per our most recent records Nuwellis Inc has 38 Employees.
Nuwellis Inc's registered address is 12988 Valley View Road, Eden Prairie, MN, United States, 55344.
You can get more information about it from Nuwellis Inc's website at https://www.nuwellis.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NUWE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
